New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer.

MLA

Cogan, Jacob C., et al. “New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer.” JNCI: Journal of the National Cancer Institute, vol. 114, no. 12, Dec. 2022, pp. 1698–705. EBSCOhost, https://doi.org/10.1093/jnci/djac170.

APA

Cogan, J. C., Raghunathan, R. R., Beauchemin, M. P., Accordino, M. K., Huang, Y., Elkin, E. B., Melamed, A., Wright, J. D., & Hershman, D. L. (2022). New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer. JNCI: Journal of the National Cancer Institute, 114(12), 1698–1705. https://doi.org/10.1093/jnci/djac170

Chicago

Cogan, Jacob C, Rohit R Raghunathan, Melissa P Beauchemin, Melissa K Accordino, Yongmei Huang, Elena B Elkin, Alexander Melamed, Jason D Wright, and Dawn L Hershman. 2022. “New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer.” JNCI: Journal of the National Cancer Institute 114 (12): 1698–1705. doi:10.1093/jnci/djac170.